Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > Crash

<< Previous

Bullboard Posts

Next >>

Comment by MrMonkon Jul 09, 2015 10:12am

106 Views

Post# 23906810

RE:Crash

I wouldn't read too much into it. Logic doesn't always prevail in the stock market. It's fruitless trying to determine why some people sell - they have their reasons (which are not always aligned with our reasons). China is a mess. It's the largest gold-buying nation in the world, and their population is likely in for a rough ride. The stock market is crashing, wealthy is evaporating. Gold and silver may need to be liquidated by many citizens to access cash to live, to put food on the table. As far as I'm concerned, the fundaments at NOX are as good as ever, and any price weakness is an opportunity to add to our positions. - MM

<< Previous

Bullboard Posts

Next >>

Opawica seeks drill permits for Bazooka Gold Targets in Abitibi